FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer
The US Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Etcamah (camizestrant), used with a…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Astrazeneca's #AstraZeneca'sEtcamah #Etcamah #FDA #PharmaceuticalTechnology #TheUSFoodandDrugAdministration
https://www.europesays.com/britain/119211/